University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada; Vancouver General Hospital, Division of Anatomical Pathology, Vancouver, Canada.
Institute of Pathology, Friedrichshafen, Germany.
Pathology. 2018 Feb;50(2):214-221. doi: 10.1016/j.pathol.2017.10.007. Epub 2017 Dec 14.
Many ovarian endometrioid carcinomas present with concurrent endometrial carcinoma, and these organ-confined, low-grade synchronous endometrial and ovarian tumours consistently behave as independent primary tumours, rather than a single advanced-stage carcinoma; they are associated with a very favourable prognosis and there is no need for adjuvant treatment. This phenomenon of synchronous tumours involving two or more sites within the female reproductive tract is well recognised, occurring in 1-2% of cases. Although some tumours can be recognised as metastasis, in many the relationship between the synchronous tumours is uncertain. Recently, application of next generation sequencing to synchronous endometrial and ovarian carcinomas has shed light on the relationship between these tumours, but raised more questions about the biology of this curious phenomenon. Herein, we review synchronous tumours involving more than one site in the female genital tract, discuss the pathogenesis, and offer guidelines for how to handle in routine practice.
许多卵巢子宫内膜样癌伴有同时性子宫内膜癌,这些局限于器官的、低级别、同时性子宫内膜和卵巢肿瘤通常表现为独立的原发性肿瘤,而不是单一的晚期癌;它们具有非常有利的预后,不需要辅助治疗。这种涉及女性生殖道两个或多个部位的同步肿瘤现象是众所周知的,在 1-2%的病例中发生。尽管一些肿瘤可以被认为是转移,但在许多情况下,同步肿瘤之间的关系是不确定的。最近,下一代测序技术在同时性子宫内膜和卵巢癌中的应用揭示了这些肿瘤之间的关系,但对这种奇特现象的生物学提出了更多的问题。在此,我们回顾了涉及女性生殖道多个部位的同步肿瘤,讨论了其发病机制,并就如何在常规实践中处理这些肿瘤提供了指导原则。